Modeling of Production Industrial Process of the Drug Flocalin and Search of its Optimally Effective Dose for Treatment of Heart Diseases

by R. B. Strutynskyi, O. O. Moibenko, V. A. Chebanov, Yu. Horobets
Published 2013

Influence of flocalin on development of apoptosis and necrosis at anoxia-reoxygenation of culture rats neonatal cardiomyocytes

by R. B. Strutynskyi, V. S. Nahibin, N. A. Strutynska, O. R. Yanchii, O. O. Moibenko
Published 2013

The influence of activation of the atp-sensitive potassium channels by flocalin on the function of the cardiovascular system

by R. B. Strutynskyi, R. A. Rovenets, N. A. Strutynska, O. P. Neshcheret, O. O. Moibenko
Published 2013

New fluorine-containing openers of atp-sensitive potassium channels flokalin and tioflokalin inhibit calcium-induced mitochondrial pore opening in rat hearts

by N. A. Strutynska, R. B. Strutynskyi, S. V. Chorna, O. M. Semenykhina, L. A. Mys, O. O. Moibenko, V. F. Sahach
Published 2013

Biochemical mechanisms of KATP channels opener flocalin (medical form) cardioprotective action at ischemia–reperfusion of myocardium

by R. B. Strutynskyi, A. V. Kotsiuruba, R. A. Rovenets, N. A. Strutynska, Yu. L. Yahupolskyi, V. F. Sahach, O. O. Moibenko
Published 2013

Development of New Openers of ATP-Sensitive Potassium Channels of the Cell Membranes

by R. B. Strutynskyi, N. A. Strutynska, O. P. Maksymiuk, M. O. Platonov, O. M. Boiko, O. V. Vasylchenko, I. M. Fedianovych, Ye. Dosenko, O. O. Kryshtal
Published 2016